This year, an unspecified number of drug developers will be eligible to take part in a pilot of the new US Food and Drug Administration (FDA) Commissioner’s National Priority Voucher (CNPV) program, ...
The Centers for Medicare & Medicaid Services has announced the selection of 15 prescription drugs for the third cycle of the Medicare Drug Price Negotiation Program. These are high-cost drugs covered ...
Rigorous answers about the program’s effects on drug innovation are still a ways off. However, some information about possible changes in beneficiary access is starting to trickle in as we approach ...
February 26, 2026 - A newly released advisory by the U.S. Department of Health and Human Services' Office of Inspector General (HHS OIG) on how direct-to-consumer (DTC) prescription drug programs ...
Starting in 2026, Medicare will launch two pilot programs, GLOBE and GUARD, aimed at reducing prescription drug costs for beneficiaries. These initiatives promise to test innovative pricing models, ...
As the Trump administration begins to make its mark on the Medicare drug price negotiation program, litigation over the program continues. In the two years since the first case challenging the program ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results